Research Programs

The research activities of the Section of Rheumatology extend from laboratory based basic science investigations to patient care initiatives aimed at improving diagnosis and treatment. Our research laboratories enjoy excellent support from federal agencies (such as the National Institutes of Health) and private foundations (such as the Arthritis Foundation). The success of our research derives from strong interactions and collaborations with other entities at The University of Chicago interested in the prevention and treatment of autoimmune diseases. All basic researchers in the Section of Rheumatology are members of the Committee on Immunology, an interactive group that comprises all faculty members of The University of Chicago with a research interest in Immunology. The Committee on Immunology includes world-renowned lymphocyte experts, including Albert Bendelac, the Committee’s chairman, Harinder Singh and Ursula Storb. In addition, the basic researchers of the Section of Rheumatology have strong ties with The University of Chicago Knapp Center for Lupus and Immunology Research, a research center lead by the member of the National Academy of Sciences, Martin Weigert, a leader in the field of B cell biology.

Clinical research activities of the section include the testing of diagnostic methods and therapeutic agents developed either at The University of Chicago or under outside auspices such as pharmaceutical manufacturers or colleagues in the academic community nationwide. Current and recent testing of therapies developed at The University of Chicago includes studies aimed at modifying the course of disease such as rheumatoid arthritis, psoriatic arthritis and scleroderma. Patients are also involved in studies on systemic lupus, osteoarthritis, gout, and inflammatory muscle disease.